Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01482559Phase 3Terminated
Phase 3, randomised trial of dopamine in hypotension (2 arms), sponsored by University College Cork. Primary endpoints: Survival to 36 weeks postmenstrual age free of severe brain injury and Survival without moderate or serious disability as defined using consensus criteria for neurodevelopmental impairment at 2 years. Started Feb 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01482559.